SITC Resource Library

Presentation slides and video from the 2023 Advances in Cancer Immunotherapy^™ Series: A Focus on Pharmacists were presented virtually on September 14, 2023.

Program Organizers

• Suzanne Jones, PharmD – Sarah Cannon Research Institute
• Eve Segal, PharmD, BCOP – University of Washington/Fred Hutchinson Cancer Center

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Program Learning Objectives

• Identify adverse drug-drug reactions in cancer immunotherapy.
• Describe the mechanisms of action for cellular therapies and bispecifics in clinical application.
• Discuss the use of immunotherapy treatments in an outpatient setting.

You can view the program agenda here.

Please note on-demand recordings are not available for continuing education credits.